Download PDF
1 / Pages

Other users also viewed these articles

Biological treatment patterns in patients with inflammatory joint diseases. Retrospective study with 4 years follow-up Juan D. Cañete; Antonio Naranjo; Javier Calvo; Carmen Ordás; Belén Aragón; Gonzalo Nocea; Montse Roset; Antonio Fernández-Nebro;
Reumatol Clin. 2020;16:447-54
Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study Josefina Cortés-Hernández; Carlos Marras Fernández-Cid; Jose Luis Andreu Sánchez; Jaime Calvo Alén; Angel M. García-Aparicio; Elvira Díez Álvarez; Francisco Javier Hidalgo Bermejo; Carlos Coronell; Alessandra Perna; Josep Ordi Ros;
Reumatol Clin. 2023;19:312-8
Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology Javier Narváez; Myriam Aburto; Daniel Seoane-Mato; Gema Bonilla; Orlando Acosta; Gloria Candelas; Esteban Cano-Jiménez; Iván Castellví; José María González-Ruiz; Héctor Corominas; Belén López-Muñiz; María Martín-López; Alejandro Robles-Pérez; Natalia Mena-Vázquez; José Antonio Rodríguez-Portal; Ana María Ortiz; Cristina Sabater-Abad; Isabel Castrejón; Raquel dos Santos; Sandra Garrote-Corral; Jesús Maese; Lucía Silva-Fernández; Santos Castañeda; Claudia Valenzuela;
Reumatol Clin. 2023;19:74-81